Serum uric acid-to-albumin ratio as a novel predictor of all-cause mortality and cardiovascular events in hemodialysis patients: a retrospective cohort study
Frontiers in Nutrition · 14.07.2026 · 13
DOI: 10.3389/fnut.2026.1818356 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Frontiers in Nutrition, online erschienen am 14.07.2026. Verfasst von Qin Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Cardiovascular disease (CVD) is the leading cause of death in patients undergoing hemodialysis. The uric acid-to-albumin ratio (UAR), a novel marker, has been linked to cardiovascular diseases. However, its role in patients undergoing hemodialysis has not yet been studied. We aimed to investigate the association between UAR and the all-cause mortality and CVD events in hemodialysis patients.
Methods
This single center retrospective cohort study was conducted between January 2021 and April 2024. Based on baseline UAR values, patients were categorized into tertiles. The associations between UAR and clinical outcomes were examined using Univariate and multivariate Cox regression models. Kaplan–Meier curves were used to estimate cumulative survival and CVD-free survival rates.
Results
A total of 310 patients undergoing hemodialysis were included. During the 40-month follow-up period, 101 (32.6%) died, and 105 (33.9%) experienced new-onset CVD events. Kaplan–Meier survival curves showed significantly higher mortality rates in the middle and high UAR groups than in the low UAR group (Log rank= 10.684, P = 0.005). Patients in high UAR group were more likely to experience CVD events (Log rank= 14.006, P = 0.001). Multivariate Cox regression analysis revealed that, even after adjustment for traditional risk factors, high UAR remained significantly associated with an increased risk of all-cause mortality and new-onset CVD events (HR: 2.431, 95% CI: 1.407–4.200, P = 0.001; HR: 2.163, 95% CI: 1.304–3.588, P = 0.003; respectively).
Conclusion
This study demonstrates for the first time that UAR is independently and significantly associated with all-cause mortality and CVD events in patients undergoing hemodialysis. These findings position UAR as a composite biomarker integrating inflammatory, metabolic, and nutritional pathways and provide a novel perspective for improving outcomes in patients undergoing hemodialysis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nephrology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Zitieren
APA
Zhou, Q., Guan, Q., Xu, L., Bai, H., Chen, W., Xingruo, Z., & Liu, C. (2026). Serum uric acid-to-albumin ratio as a novel predictor of all-cause mortality and cardiovascular events in hemodialysis patients: a retrospective cohort study. Frontiers in Nutrition, 13. https://doi.org/10.3389/fnut.2026.1818356
Vancouver
Zhou Q, Guan Q, Xu L, Bai H, Chen W, Xingruo Z, et al. Serum uric acid-to-albumin ratio as a novel predictor of all-cause mortality and cardiovascular events in hemodialysis patients: a retrospective cohort study. Frontiers in Nutrition. 2026;13. doi:10.3389/fnut.2026.1818356
BibTeX
@article{Zhou2026,
author = {Zhou, Qin and Guan, Qian and Xu, Li and Bai, Haitao and Chen, Wenli and Xingruo, Zeng and Liu, Changxuan},
title = {Serum uric acid-to-albumin ratio as a novel predictor of all-cause mortality and cardiovascular events in hemodialysis patients: a retrospective cohort study},
journal = {Frontiers in Nutrition},
year = {2026},
volume = {13},
doi = {10.3389/fnut.2026.1818356}
}
EUVIMED